Vilasco Myriam, Communal Laudine, Hugon-Rodin Justine, Penault-Llorca Frédérique, Mourra Najat, Wu Zherui, Forgez Patricia, Gompel Anne
INSERM-UPMC Université Paris 06, UMRS 938, Hôpital Saint Antoine, 75012, Paris, France.
Unité de Gynécologie Endocrinienne, Université Paris Descartes, AP-HP, Cochin Port Royal, 53, Avenue de l'Observatoire, 75014 , Paris, France.
Breast Cancer Res Treat. 2016 Apr;156(2):401-2. doi: 10.1007/s10549-016-3712-4.
Erratum to: Breast Cancer Res Treat (2013),142:283–296,DOI 10.1007/s10549-013-2722-8. In the original publication of the article, the blot corresponding to the total P38 protein content for the conditions siCtl and siBRCA1 in Fig. 7a was incorrectly laid out. The corrected Fig. 7a is given in this erratum.The
《乳腺癌研究与治疗》（2013年）第142卷，第283 - 296页，DOI：10.1007/s10549-013-2722-8的勘误。在该文章的原始发表中，图7a中对应于siCtl和siBRCA1条件下总P38蛋白含量的印迹排版错误。本勘误给出了更正后的图7a。
